The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 164:1356-1363, September 2007
doi: 10.1176/appi.ajp.2007.07030454
© 2007 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Additional Data
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gibbons, R. D.
* Articles by Mann, J. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gibbons, R. D.
* Articles by Mann, J. J.
Related Collections
* Health Policy and Legislation
* Suicide
* Antidepressants
*Related Article

Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents

Robert D. Gibbons, Ph.D., C. Hendricks Brown, Ph.D., Kwan Hur, Ph.D., Sue M. Marcus, Ph.D., Dulal K. Bhaumik, Ph.D., Joëlle A. Erkens, Pharm.D., Ph.D., Ron M.C. Herings, Pharm.D., Ph.D., and J. John Mann, M.D.

OBJECTIVE: In 2003 and 2004, U.S. and European regulators issued public health warnings about a possible association between antidepressants and suicidal thinking and behavior. The authors assessed whether these warnings discouraged use of antidepressants in children and adolescents and whether they led to increases in suicide rates as a result of untreated depression. METHOD: The authors examined U.S. and Dutch data on prescription rates for selective serotonin reuptake inhibitors (SSRIs) from 2003 to 2005 in children and adolescents (patients up to age 19), as well as suicide rates for children and adolescents, using available data (through 2004 in the United States and through 2005 in the Netherlands). They used Poisson regression analyses to determine the overall association between antidepressant prescription rates and suicide rates, adjusted for sex and age, during the periods preceding and immediately following the public health warnings. RESULTS: SSRI prescriptions for youths decreased by approximately 22% in both the United States and the Netherlands after the warnings were issued. In the Netherlands, the youth suicide rate increased by 49% between 2003 and 2005 and shows a significant inverse association with SSRI prescriptions. In the United States, youth suicide rates increased by 14% between 2003 and 2004, which is the largest year-to-year change in suicide rates in this population since the Centers for Disease Control and Prevention began systematically collecting suicide data in 1979. CONCLUSIONS: In both the United States and the Netherlands, SSRI prescriptions for children and adolescents decreased after U.S. and European regulatory agencies issued warnings about a possible suicide risk with antidepressant use in pediatric patients, and these decreases were associated with increases in suicide rates in children and adolescents.


Related Article:

In This Issue
Am J Psychiatry 2007 164: A36. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
J. S. Harman, M. J. Edlund, and J. C. Fortney
Trends in Antidepressant Utilization From 2001 to 2004
Psychiatr Serv, May 1, 2009; 60(5): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
S. H. Busch and C. L. Barry
Pediatric Antidepressant Use After The Black-Box Warning
Health Aff., May 1, 2009; 28(3): 724 - 733.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
H. I Weisberg, V. C Hayden, and V. P Pontes
Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
Clinical Trials, April 1, 2009; 6(2): 109 - 118.
[Abstract] [PDF]


Home page
CMAJHome page
R. Gibbons PhD and J. J. Mann MD
Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression
Can. Med. Assoc. J., February 3, 2009; 180(3): 270 - 271.
[Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. S. Callender and J. M. Eagles
Coping with suicide: a perspective from Scotland: Invited commentary on... Coping with a coroner's Inquest
Advan. Psychiatr. Treat., January 1, 2009; 15(1): 17 - 22.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
M. K. Nock, G. Borges, E. J. Bromet, C. B. Cha, R. C. Kessler, and S. Lee
Suicide and Suicidal Behavior
Epidemiol. Rev., November 1, 2008; 30(1): 133 - 154.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
I. Anghelescu and F. Regen
SSRI Tapering and Suicidal Ideation in the TORDIA Study for Treatment of Depressed Adolescents
JAMA, June 18, 2008; 299(23): 2745 - 2746.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol, June 1, 2008; 22(4): 343 - 396.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. S. March and for the TADS Team
Tailoring Treatment to Parental Values: A Comment on TADS--Reply
Arch Gen Psychiatry, June 1, 2008; 65(6): 723 - 724.
[Full Text] [PDF]


Home page
CMAJHome page
L. Y. Katz MD, A. L. Kozyrskyj PhD, H. J. Prior MSc, M. W. Enns MD, B. J. Cox PhD, and J. Sareen MD
Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults
Can. Med. Assoc. J., April 8, 2008; 178(8): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. M. Mamdani PharmD MPH
Health advisories: when good intentions go bad
Can. Med. Assoc. J., April 8, 2008; 178(8): 1025 - 1026.
[Full Text] [PDF]


Home page
BMJHome page
B. W Wheeler, D. Gunnell, C. Metcalfe, P. Stephens, and R. M Martin
The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study
BMJ, March 8, 2008; 336(7643): 542 - 545.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. Simon
Antidepressants and suicide
BMJ, March 8, 2008; 336(7643): 515 - 516.
[Full Text] [PDF]


Home page
Am J Mens HealthHome page
D. J. Breland and M. J. Park
Depression: Focus on the Adolescent Male
American Journal of Men's Health, March 1, 2008; 2(1): 87 - 93.
[PDF]


Home page
Am. J. PsychiatryHome page
B. Vitiello and J. L. Pearson
A Depressed Adolescent at High Risk of Suicidal Behavior
Am J Psychiatry, March 1, 2008; 165(3): 323 - 328.
[Full Text] [PDF]


Home page
Inj. Prev.Home page
R. M Bossarte and E. D Caine
Increase in US youth suicide rates 2004
Inj. Prev., February 1, 2008; 14(1): 2 - 3.
[Full Text] [PDF]


Home page
FocusHome page
P. Clayton and T. Auster
Strategies for the Prevention and Treatment of Suicidal Behavior
Focus, January 1, 2008; 6(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. JUREIDINI
The Black Box Warning: Decreased Prescriptions and Increased Youth Suicide?
Am J Psychiatry, December 1, 2007; 164(12): 1907 - 1907.
[Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
B Dubicka and P Wilkinson
Evidence-based treatment of adolescent major depression
Evid. Based Ment. Health, November 1, 2007; 10(4): 100 - 102.
[Full Text] [PDF]


Home page
JWatch PediatricsHome page
Worrisome Data About Youth Suicide
Journal Watch Pediatrics and Adolescent Medicine, October 31, 2007; 2007(1031): 3 - 3.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org